Shell Midstream Partners, L.P. (NYSE:SHLX) shares increased 2.10% in last trading session and ended the day at $34.03. SHLX has a return on assets of 25.80%. Shell Midstream Partners, L.P. (NYSE:SHLX) quarterly performance is -7.57%.
Shell Midstream Partners, L.P. (NYSE:SHLX) commences an underwritten public offering of 8.5 mln common units representing limited partner interests. Co expects to use the net proceeds from this offering and from its general partner’s proportionate capital contribution to repay borrowings outstanding under Shell Midstream Partners’ revolving credit facilities and for general partnership purposes, which may include funding working capital, capital expenditures or acquisitions.
Marriott International, Inc. (NASDAQ:MAR) ended the last trading day at $70.92. Company weekly volatility is calculated as 2.00% and price to cash ratio as 187.26. Marriott International, Inc. (NASDAQ:MAR) showed a weekly performance of 0.72%.
Marriott International, Inc. (NASDAQ:MAR) announced it continues to expect strong RevPAR and unit growth in 2016. The company expects comparable systemwideRevPAR on a constant dollar basis in North America, outside North America and worldwide will increase 2 to 4 percent in the first quarter of 2016 and 3 to 5 percent for full year 2016, likely toward the upper end of the full year range.
On 22 March, Prothena Corporation plc (NASDAQ:PRTA) shares increased 1.33% and was closed at $41.16. PRTA EPS growth in last 5 year was -25.30%. Prothena Corporation plc (NASDAQ:PRTA) year to date (YTD) performance is -39.57%.
On March 16, Prothena Corporation plc (NASDAQ:PRTA) announced the publication of preclinical data demonstrating that the company`s conformation-specific antibodies developed against misfoldedtransthyretin (TTR) bind to and facilitate in vitro cellular uptake of amyloidogenic forms of TTR. The research was published online on March 16, 2016 in the peer-reviewed journal Amyloid in a manuscript titled “Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin.”
Abraxas Petroleum Corp. (NASDAQ:AXAS) shares moved down -4.42% in last trading session and ended the day at $1.08. AXAS Gross Margin is 55.50% and its has a return on assets of -38.20%. Abraxas Petroleum Corp. (NASDAQ:AXAS) quarterly performance is 21.35%.
Abraxas Petroleum Corp. (NASDAQ:AXAS) reported financial and operating results for the three and twelve months ended December 31, 2015.Net loss for the three months ended December 31, 2015 was $67.4 million, or $0.64 per share, compared to net income of $30.1 million, or $0.29 per share, for the three months ended December 31, 2014.
NanoViricides, Inc. (NYSEMKT:NNVC) caters to the Healthcare space. Its weekly performance is 11.72%. On the last day of trading company shares ended up at $3.05. NanoViricides, Inc. (NYSEMKT:NNVC) distance from 50-day simple moving average (SMA50) is 61.73%.
NanoViricides, Inc. (NYSEMKT:NNVC)announced that its CEO, Dr. Eugene Seymour, was interviewed by Jane King of Small Cap Nation (“SCN”). SCN has published a video clip of this interview on March 1, 2016 on YouTube (https://www.youtube.com/watch?v=9Xc9nBGv4U4).Dr. Seymour discussed the Company’s current status and achievements. While the Company currently has approximately a dozen drug development programs in its research and development pipeline, it is still preclinical at present. NanoViricides is currently focused on developing a drug for the herpes infection of the eye, i.e. herpes keratitis, which can lead to blindness and the need for corneal transplants.